Changing the burden of COPD mortality

References

• AlsaeediASinDDMcAlisterFA2002The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trialsAm J Med113596512106623
   PubMed Web of Science ®Google Scholar
• [ALA] American Lung Association EaSU, Research and Scientific Affairs2004Trends in chronic bronchitis and emphysema: morbidity and mortalityNew York, NYAmerican Lung Association
   Google Scholar
• AnthonisenNRConnettJEKileyJP1994Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA27214975057966841
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPL2002Hospitalizations and mortality in the Lung Health StudyAm J Respir Crit Care Med166333912153966
   PubMed Web of Science ®Google Scholar
• AnthonisenNRSkeansMAWiseRA2005The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med142233915710956
   PubMed Web of Science ®Google Scholar
• AntoJMVermeirePVestboJ2001Epidemiology of chronic obstructive pulmonary diseaseEur Respir J179829411488336
   PubMed Web of Science ®Google Scholar
• BardiGPierotelloRDesideriM2000Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled studyEur Respir J159810410678628
   PubMed Web of Science ®Google Scholar
• BarreiroTJPerilloI2004An approach to interpreting spirometryAm Fam Physician6911071415023009
   PubMed Web of Science ®Google Scholar
• BergerJSSanbornTAShermanW2004Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary interventionAm J Cardiol946495115342301
   PubMed Web of Science ®Google Scholar
• BergofskyEH1983Tissue oxygen delivery and cor pulmonale in chronic obstructive pulmonary diseaseN Engl J Med308109246835322
   PubMed Web of Science ®Google Scholar
• BraghiroliAZaccariaSIoliF1997Pulmonary failure as a cause of death in COPDMonaldi Arch Chest Dis5217059203816
   PubMedGoogle Scholar
• BuistAS1997The US Lung Health StudyRespirology230379525302
   PubMedGoogle Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ320129730310807619
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWATS/ERS committee members2004Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• ChaouatAWeitzenblumEKesslerR1999A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patientsEur Respir J141002810596681
   PubMed Web of Science ®Google Scholar
• COMBIVENT Inhalation Aerosol Study Group1994In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trialChest105141198181328
   PubMed Web of Science ®Google Scholar
• COMBIVENT Inhalation Solution Study Group1997Routine nebulized ipratropium and albuterol together are better than either alone in COPDChest1121514219404747
   PubMed Web of Science ®Google Scholar
• ConfalonieriMPotenaACarboneG1999Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilationAm J Respir Crit Care Med16015859110556125
   PubMed Web of Science ®Google Scholar
• CrapoROMorrisAH1989Pulmonary function testing: sources of error in measurement and interpretationSouth Med J8287592665129
   PubMed Web of Science ®Google Scholar
• CrockettAJCranstonJMMossJR1994Trends in chronic obstructive pulmonary disease mortality in AustraliaMed J Aust16160037968728
   PubMed Web of Science ®Google Scholar
• CurkendallSMJonesJKGoehringE2004Cardiovascular morbidity and mortality among patients with chronic obstructive pulmonary disease (COPD) [abstract]Am J Respir Crit Care Med169A220
   Google Scholar
• DecramerMCelliBTashkinDP2004Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: The Uplift trialCOPD13031217136995
   PubMedGoogle Scholar
• DecramerMGosselinkRBartschP2005Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11–12 March 2004Thorax60343915790992
   PubMedGoogle Scholar
• [ERS] European Respiratory Society and European Lung Foundation2003Section 3: Chronic obstructive pulmonary diseaseEuropean Lung White BookSheffieldEuropean Respiratory Society3443
   Google Scholar
• FanVSBrysonCLCurtisJR2003Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysisAm J Respir Crit Care Med16814889414525798
   PubMed Web of Science ®Google Scholar
• FerreiraIMBrooksDLacasseY2005Nutritional supplementation for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev2 article nr CD000998
   Web of Science ®Google Scholar
• FishmanAMartinezFNaunheimK2003A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaN Engl J Med34820597312759479
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanA2004Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax595748015223864
   PubMed Web of Science ®Google Scholar
• GOLD2005Global Initiative for Chronic Obstructive Lung Disease [online]Accessed 9 November 2005 URL: www.goldcopd.com
   Google Scholar
• GóreckaDGorzelakKSliwinskiP1997Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemiaThorax5267499337824
   PubMed Web of Science ®Google Scholar
• GretenFREckmannLGretenTF2004IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancerCell1182859615294155
   PubMed Web of Science ®Google Scholar
• HansellAHollowellJMcNieceR2003aValidity and interpretation of mortality, health service and survey data on COPD and asthma in EnglandEur Respir J212798612608442
   PubMed Web of Science ®Google Scholar
• HansellALWalkJASorianoJB2003bWhat do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysisEur Respir J228091414621089
   PubMed Web of Science ®Google Scholar
• HardieJABuistASVollmerWM2002Risk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J2011172212449163
   PubMed Web of Science ®Google Scholar
• HoggJCChuFUtokaparchS2004The nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med35026455315215480
   PubMed Web of Science ®Google Scholar
• HosenpudJDBennettLEKeckBM1998Effect of diagnosis on survival benefit of lung transplantation for end-stage lung diseaseLancet3512479433425
   PubMed Web of Science ®Google Scholar
• HurdSS2000International efforts directed at attacking the problem of COPDChest117S3368
   Web of Science ®Google Scholar
• JenkinsMARubinfieldARRRobertsonCF1992Accuracy of asthma death statistics in AustraliaAustral J Pub Health164279
   Google Scholar
• JonesSEPackhamSHebdenM1998Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long-term follow up and effect on survivalThorax5349589713450
   PubMed Web of Science ®Google Scholar
• KawakamiYKishiFYamamotoH1983Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary diseaseN Engl J Med308104596403862
   PubMed Web of Science ®Google Scholar
• KazerouniNAlversonCJReddSC2004Sex differences in COPD and lung cancer mortality trends: United States, 1968–1999J Womens Health131723
   PubMed Web of Science ®Google Scholar
• KeistinenTTuuponenTKivelaSL1998Survival experience of the population needing hospital treatment for asthma or COPD at age 50–54 yearsRespir Med92568729692124
   PubMed Web of Science ®Google Scholar
• KiriVABettoncelliGTestiR2005aInhaled corticosteroids are more effective in COPD patients when used with LABA than with SABARespir Med9911152415921904
   PubMed Web of Science ®Google Scholar
• KiriVAPrideNBSorianoJB2005bInhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time biasAm J Respir Crit Care Med172460415901610
   PubMed Web of Science ®Google Scholar
• LadenFSchwartzJSpeizerFE2006Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities StudyAm J Respir Crit Care Med1736677216424447
   PubMed Web of Science ®Google Scholar
• LesauskaiteV2003Age-related trends in mortality from COPD in Lithuania, 1989 to 1998Chest12490312853507
   PubMed Web of Science ®Google Scholar
• LightowlerJVWedzichaJAElliottMW2003Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysisBMJ32618512543832
   PubMed Web of Science ®Google Scholar
• LoddenkemperRGibsonGJSibilleY2003European White Lung Book: The First Comprehensive Survey on Respiratory Health in EuropeSheffieldEuropean Respiratory Society
   Google Scholar
• LopezADShibuyaKRaoC2006Chronic obstructive pulmonary disease: current burden and future projectionsEur Respir J2739741216452599
   PubMed Web of Science ®Google Scholar
• [LHSRG] Lung Health Study Research Group2000Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med3431902911136260
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16610849112379552
   PubMed Web of Science ®Google Scholar
• ManninoDMBrownCGiovinoGA1997Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality dataAm J Respir Crit Care Med15681489309998
   PubMed Web of Science ®Google Scholar
• ManninoDMGagnonRCPettyTL2000Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994Arch Intern Med1601683910847262
   PubMed Web of Science ®Google Scholar
• ManninoDMHomaDMAkinbamiLJ2002Chronic obstructive pulmonary disease surveillance: United States, 1971–2000MMWR Surveillance Summaries51116
   PubMed Web of Science ®Google Scholar
• ManninoDMBuistASPettyTL2003Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyThorax583889312728157
   PubMed Web of Science ®Google Scholar
• MarquisKDebigareRLacasseY2002Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1668091312231489
   PubMed Web of Science ®Google Scholar
• MatsubaKWrightJLWiggsBR1989The changes in airways structure associated with reduced forced expiratory volume in one secondEur Respir J283492806508
   PubMed Web of Science ®Google Scholar
• [MRCWP] Medical Research Council Working Party1981Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysemaLancet168166110912
   PubMed Web of Science ®Google Scholar
• MenezesAMPerez-PadillaRJardimJB2005Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet36618758116310554
   PubMed Web of Science ®Google Scholar
• MukhopadhyayTRothJAMaxwellSA1995Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinomaOncogene1199910037675461
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997aAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet34914985049167458
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997bGlobal mortality, disability, and the contribution of risk factors: Global Burden of Disease StudyLancet3491436429164317
   PubMed Web of Science ®Google Scholar
• MurrayCJLopezAD1997cMortality by cause for eight regions of the world: Global Burden of Disease StudyLancet3491269769142060
   PubMed Web of Science ®Google Scholar
• [NHLBI] National Institutes of Health, National Heart Lung and Blood Institute2004Morbidity & mortality: 2004 chart book on cardiovascular, lung, and blood diseases190
   Google Scholar
• NicholKLNordinJMulloolyJ2003Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderlyN Engl J Med34813223212672859
   PubMed Web of Science ®Google Scholar
• [NOTTG] Nocturnal Oxygen Therapy Trial Group1980Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trialAnn Intern Med9339186776858
   PubMed Web of Science ®Google Scholar
• O’DonnellDERevillSMWebbKA2001Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med164770711549531
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLA1999Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med34019485310379018
   PubMed Web of Science ®Google Scholar
• PauwelsRARabeKF2004Burden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet3646132015313363
   PubMed Web of Science ®Google Scholar
• PettyTLBlissPL2000Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited)Respir Care452041110771792
   PubMedGoogle Scholar
• PikarskyEPoratRMSteinI2004NF-kappaB functions as a tumour promoter in inflammation-associated cancerNature431461615329734
   PubMed Web of Science ®Google Scholar
• ReidDWHendrickVJAitkenTC1998Age-dependent inaccuracy of asthma death certification in Northern England, 1991–1992Eur Respir J121079839864000
   PubMed Web of Science ®Google Scholar
• RepineJEBastALankhorstI1997Oxidative stress in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med156341579279209
   PubMed Web of Science ®Google Scholar
• ScalviniSPortaRZanelliE1999Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary diseaseEur Respir J131192410836335
   PubMed Web of Science ®Google Scholar
• ScanlonPDConnettJEWallerLA2000Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health StudyAm J Respir Crit Care Med1613819010673175
   PubMed Web of Science ®Google Scholar
• ScholsAMSlangenJVolovicsL1998Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med157179179620907
   PubMed Web of Science ®Google Scholar
• ScholsA2003Nutritional modulation as part of the integrated management of chronic obstructive pulmonary diseaseProc Nutr Soc627839115018476
   PubMed Web of Science ®Google Scholar
• ScholsAMWesselingGKesterAD2001Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoidsEur Respir J173374211405508
   PubMed Web of Science ®Google Scholar
• SekineYBehniaMFujisawaT2002Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLCLung Cancer379510112057873
   PubMed Web of Science ®Google Scholar
• SinDDTuJV2000aLack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway diseaseThorax55194710679537
   PubMed Web of Science ®Google Scholar
• SinDDTuJV2000bOutpatient antibiotic therapy and short term mortality in elderly patients with chronic obstructive pulmonary diseaseCan Respir J74667111121091
   PubMedGoogle Scholar
• SinDDTuJV2001Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med164580411520719
   PubMed Web of Science ®Google Scholar
• SinDDManSF2003aInhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?Eur Respir J21260612608439
   PubMed Web of Science ®Google Scholar
• SinDDManSF2003bWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation1071514912654609
   PubMed Web of Science ®Google Scholar
• SinDDMcAlisterFAManSF2003Contemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA29023011214600189
   PubMed Web of Science ®Google Scholar
• SinDDWuLAndersonJA2005Inhaled corticosteroids and mortality in chronic obstructive pulmonary diseaseThorax60992716227327
   PubMed Web of Science ®Google Scholar
• SmythETWrightSCEvansAE1986Death from airways obstruction: accuracy of certification in Northern IrelandThorax5129378779134
   PubMed Web of Science ®Google Scholar
• SorianoJBVestboJPrideNB2002Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practiceEur Respir J208192512412670
   PubMed Web of Science ®Google Scholar
• SorianoJBKiriVAPrideNB2003Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patientsAm J Respir Med2677414720023
   PubMedGoogle Scholar
• StrömK1998Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in womenRespir Med925069519225
   PubMed Web of Science ®Google Scholar
• SuissaS2003Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studiesAm J Respir Crit Care Med168495312663327
   PubMed Web of Science ®Google Scholar
• SuissaS2004Inhaled steroids and mortality in COPD: bias from unaccounted immortal timeEur Respir J23391515065827
   PubMed Web of Science ®Google Scholar
• SunyerJAntoJMMcFarlaneD1998Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med15885169731016
   PubMed Web of Science ®Google Scholar
• SutherlandERCherniackRM2004Management of chronic obstructive pulmonary diseaseN Engl J Med35026899715215485
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezA2003Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J21748112570112
   PubMed Web of Science ®Google Scholar
• TanWC2002The global initiative for chronic obstructive lung disease: Gold standards and the Asia-Pacific perspectiveRespirology71211896894
   PubMed Web of Science ®Google Scholar
• TashkinDPAshutoshKBleeckerER1986Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center studyAm J Med8181902947465
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services2003Data fact sheetChronic obstructive pulmonary diseaseWashington, DCUSDHHS
   Google Scholar
• van der ValkPMonninkhofEvan der PalenJ2002Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyAm J Respir Crit Care Med16613586312406823
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangeP1999Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet35318192310359405
   PubMed Web of Science ®Google Scholar
• VestboJThe TORCH Study Group2004The TORCH (TOwards a Revolution in COPD Health) survival study protocolEur Respir J242061015332386
   PubMed Web of Science ®Google Scholar
• VilkmanSKeistinenTTuuponenT1997Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospitalRespiration6428149257363
   PubMed Web of Science ®Google Scholar
• WaterhouseJCFishwickDAndersonJA1999What caused death in the inhaled steroids in obstructive lung disease in Europe (ISOLDE) study? [abstract]Eur Respir J14Suppl 30387s
   Google Scholar
• WedzichaJASeemungalTAMacCallumPK2000Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost84210510959691
   PubMed Web of Science ®Google Scholar
• WeirE2004COPD death rates: projecting a female trajectoryCMAJ17033414757666
   PubMed Web of Science ®Google Scholar
• WilsonDORogersRMWrightEC1989Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing TrialAm Rev Respir Dis139143582658702
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization2002The World Health Report 2002: Reducing the Risks, Promoting Healthy LifeGenevaWHO
   Google Scholar
• [WHO] World Health Organization2004The World Health Report 2004: Changing HistoryGenevaWHO
   Google Scholar
• WrightJGChristmanJW2003The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapyAm J Respir Med2211914720003
   PubMedGoogle Scholar
• ZielinskiJMacNeeWWedzichaJ1997Causes of death in patients with COPD and chronic respiratory failureMonaldi Arch Chest Dis524379151520
   PubMedGoogle Scholar